BioPharmGuy logo
Sponsored By:
Trianni Inc.
Weekly Update Subscription
Emery Pharma
ActoGeniX is defunct.

Fate: Acquired by Intrexon, $60M, Feb 2015


------------------
If you believe any of this information is incorrect, please let us know.